16-2088550-T-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_000548.5(TSC2):c.5364T>G(p.Tyr1788*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000548.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Tuberous sclerosis 2 Uncertain:1
Frameshift variants that extend the reading frame of the C-terminal end of the TSC2 protein have been observed in individuals affected with tuberous sclerosis complex (TSC) (PMID: 21520333, 24789117, 21520333, Invitae). However, while nonsense variants that remove this very C-terminal end of the TSC2 protein have been observed in several instances, the individuals do not have clinical features consistent with TSC (Invitae). This variant has not been reported in the literature in individuals with TSC2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the TSC2 gene (p.Tyr1788*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 20 amino acids of the TSC2 protein. This variant is not expected to affect the Rap-GAP domain, which is required for tumor suppression function (PMID: 8799170, 18466115). Experimental studies are not available for this variant, and the functional significance of the deleted amino acids is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.Y1788* variant (also known as c.5364T>G), located in coding exon 41 of the TSC2 gene, results from a T to G substitution at nucleotide position 5364. This changes the amino acid from a tyrosine to a stop codon within coding exon 41. This alteration occurs at the 3' terminus of theTSC2 gene, is not expected to trigger nonsense-mediated mRNAdecay, and only impacts the last 20 amino acids of the protein. The exact functional effect of this alteration is unknown. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at